Patients
 
N %
All patients treated (at least first administration) 1,109 100.0
No ADRs 575 51.8
ADRs 534 48.2
ADRs at least “possibly“ related 299 27.0
Serious ADRs 4 0.4
Discontinued due to ADRs 98 8.8
Medically treated due to ADRs 67 6.0
First administration of the SQ-grass SLIT-tablet in the clinic    
No ADRs 649 58.5
Tolerable ADRs 440 39.7
Intolerable ADRs 20 1.8
ADRs during home treatment 318 28.7
N: Number of patients
ADR: Adverse drug reactions
SLIT:Sublingual immunotherapy
Table 2: Patients with adverse drug reactions.
Goto home»